LABORATORY CORP OF AMERICA HOLDINGS

LH - CIK 0000920148

Market cap$22.03 B

Rank#581

SEC filings3,857

LABORATORY CORP OF AMERICA HOLDINGS trades as LH and has a market capitalization of $22.03 B, making it the #581 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $13.95B, up 7.2% from the prior year and net income of $877.00M. This page tracks LABORATORY CORP OF AMERICA HOLDINGS through 3,857 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$13.95BFY 2025

Net income (latest FY)$877.00MFY 2025

Operating cash flow (latest FY)$1.64BFY 2025

Total assets (latest FY)$18.39BFY 2025

Gross margin28.8%latest FY

Net margin6.3%latest FY

Financial performance

Over the last 9 fiscal years LABORATORY CORP OF AMERICA HOLDINGS's revenue grew from $9.55B to $13.95B, a compound annual growth rate of 4.3%. Net profit margin compressed from 7.5% to 6.3% over the same period - every figure below comes from the company's audited annual filings.

LH annual revenueView details

Key statistics

Market cap: $22.03 B
Share price (derived)market cap / shares outstanding: $268.63
P/E ratio (trailing FY): 25.1
EPS (diluted)FY 2025: $10.46
Shares outstandingas of 2026-05-01: 0.08B
Total equityas of 2026-03-31: $8.73B
Return on equity: 10.0%
Long-term debtas of 2026-03-31: $5.83B

Latest filings

Filing	Type	Filed
Insider trade	4	2026-05-13
Insider sale notice	144	2026-05-11
Insider sale notice	144	2026-05-06
Quarterly report	10-Q	2026-05-04
Major company event	8-K	2026-04-30
SCHEDULE 13G	-	2026-04-28
Annual report to shareholders	ARS	2026-04-10
Proxy materials	DEFA14A	2026-04-10

Browse the full filing history (3,857 filings)

Recent press releases

Labcorp Announces 2026 First Quarter Results; Raises Full Year ...
Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance ; Net Earnings Attributable to Labcorp Holdings Inc. $ 277.8.
Labcorp Announces 2025 Fourth Quarter and Full Year Results
Company Provides 2026 Guidance. Financial results from Operations versus 2024: Revenue: Q4 of $3.52 billion vs $3.33 billion ; Full year of ...
Labcorp Announces 2025 Second Quarter Results
Revenue guidance narrowed to 7.5% to 8.6%; midpoint raised by 70 basis points · Adjusted EPS range narrowed to $16.05 to $16.50 ; midpoint raised ...
Labcorp Announces 2025 Third Quarter Results
Labcorp Announces 2025 Third Quarter Results ; Revenue Summary (Dollars in billions) ; Total Revenue. $ 3.56. $ 3.28 ; Organic ...
Labcorp Announces 2025 First Quarter Results
Adjusted EPS range of $15.70 to $16.40 ; midpoint raised $0.05; Free Cash Flow of $1.10 billion to $1.25 billion. Providing broader access to ...

Similar companies

The largest companies sharing LABORATORY CORP OF AMERICA HOLDINGS's SEC industry classification (services-medical laboratories).

NTRANatera, Inc.$31.01 B LH vs NTRA

DGXQuest Diagnostics Incorporated$22.56 B LH vs DGX

EXASExact Sciences$20.03 B LH vs EXAS

GHGuardant Health, Inc.$17.33 B LH vs GH

CAICaris Life Sciences, Inc.$4.84 B LH vs CAI

Frequently asked questions

What is LABORATORY CORP OF AMERICA HOLDINGS's market cap?

LABORATORY CORP OF AMERICA HOLDINGS (LH) has a market capitalization of $22.03 B as of 2026-06-10, ranking #581 among US-listed companies.

How much revenue does LABORATORY CORP OF AMERICA HOLDINGS make?

LABORATORY CORP OF AMERICA HOLDINGS reported revenue of $13.95B for fiscal year 2025, an increase of 7.2% year over year.

Is LABORATORY CORP OF AMERICA HOLDINGS profitable?

Yes. LABORATORY CORP OF AMERICA HOLDINGS reported net income of $877.00M in its latest fiscal year.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.